Abstract
Nobuhisa Okada, Natsuko Togawa, Tomoyuki Ishimoto, Takashi Ayaki, Takakuni Maki, Riki Matsumoto
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy–Drager syndrome)
10.1016/0022-510x(89)90219-0 · 1989
Second consensus statement on the diagnosis of multiple system atrophy
10.1212/01.wnl.0000324625.00404.15 · 2008
Multiple system atrophy: prognostic indicators of survival
10.1002/mds.25927 · 2014
Inflammation in multiple system atrophy
10.3389/fimmu.2023.1214677 · 2023
T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease
10.1007/s00401-020-02126-w · 2020
Cytokine profiling in the prefrontal cortex of Parkinson’s disease and multiple system atrophy patients
10.1016/j.nbd.2017.07.014 · 2017
IFNγ drives neuroinflammation, demyelination, and neurodegeneration in a mouse model of multiple system atrophy
10.1186/s40478-023-01710-x · 2024
A lineage of myeloid cells independent of Myb and hematopoietic stem cells
10.1126/science.1219179 · 2012
Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy
10.1371/journal.pone.0062354 · 2013
Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFα, and IFNγ concentrations are elevated in patients with atypical and idiopathic parkinsonism
10.1016/j.neulet.2008.06.040 · 2008
Early strong intrathecal inflammation in cerebellar type multiple system atrophy by cerebrospinal fluid cytokine/chemokine profiles: a case control study
10.1186/s12974-017-0863-0 · 2017
Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes
10.1186/s12974-018-1339-6 · 2018
CMSAR consortium, Cerebrospinal fluid cytokines in multiple system atrophy: a cross-sectional Catalan MSA registry study
10.1016/j.parkreldis.2019.05.040 · 2019
Microglial activation parallels system degeneration in multiple system atrophy
10.1093/jnen/63.1.43 · 2004
NLRP3 inflammasome-related proteins are upregulated in the putamen of patients with multiple system atrophy
10.1093/jnen/nly090 · 2018
Role of complement activation and disruption of the blood–brain barrier in the pathogenesis of multiple system atrophy
10.1016/j.neulet.2024.137642 · 2024
Blood–brain barrier impairment is functionally correlated with clinical severity in patients of multiple system atrophy
10.1016/j.neurobiolaging.2009.12.017 · 2011
Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model
10.1007/s12640-011-9294-3 · 2012
Failure of neuroprotection despite microglial suppression by delayed-start myeloperoxidase inhibition in a model of advanced multiple system atrophy: clinical implications
10.1007/s12640-015-9547-7 · 2015
CSF1R-mediated myeloid cell depletion prolongs lifespan but aggravates distinct motor symptoms in a model of multiple system atrophy
10.1523/jneurosci.0417-22.2022 · 2022
FTY720-mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in multiple system atrophy mouse models
10.1016/j.expneurol.2019.113120 · 2020
Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice
10.1161/01.str.0000259709.16654.8f · 2007
Fate mapping of peripherally-derived macrophages after traumatic brain injury in mice reveals a long-lasting population with a distinct transcriptomic signature
10.1038/s41467-025-63952-8 · 2025
CCR2/CCR5 antagonism with cenicriviroc relieves neuropathic pain induced by sciatic nerve injury and delays morphine tolerance in mice
10.1016/j.bcp.2026.117773 · 2026
No additional external references are available.